Filling and mining the reactive metabolite target protein database

Chemico-Biological Interactions

Volumn 179, Issue 1, 2009, Pages 38-44

  Hanzlik, Robert P ^a   Fang, Jianwen ^a   Koen, Yakov M ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Covalent binding; Cytotoxicity; Hepatotoxicity; Post translational modification; Reactive metabolites

Indexed keywords

1,1,1 TRICHLOROETHANE; 4 DIMETHYLAMINOAZOBENZENE; ACRYLAMIDE; ACRYLONITRILE; AMINOGLUTETHIMIDE; ATRAZINE; BENZENE; BROMOBENZENE; BUTYLCRESOL; CELL PROTEIN; CHAPERONE; CHLOROFORM; COCAINE; DICLOFENAC; DRUG METABOLIZING ENZYME; ELECTROPHILE; ETHYLENE OXIDE; FREE RADICAL; HALOTHANE; MENADIONE; METACETAMOL; MOLINATE; MYCOPHENOLIC ACID; NAPHTHALENE; NUCLEOPHILE; PARACETAMOL; THIOBENZAMIDE; VINYLIDENE CHLORIDE; XENOBIOTIC AGENT; ZOMEPIRAC;

APOPTOSIS; BIOINFORMATICS; BIOMICS; CHEMICAL STRUCTURE; COVALENT BOND; CYTOTOXICITY; DRUG METABOLISM; GENOTOXICITY; HUMAN; INFORMATION PROCESSING; LIVER TOXICITY; METABOLITE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DATABASE; PROTEIN FOLDING; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REACTIVE METABOLITE TARGET PROTEIN DATABASE; REVIEW; TOXICOGENOMICS; XENOBIOTIC METABOLISM;

DATABASES, PROTEIN; INFORMATION STORAGE AND RETRIEVAL; PROTEIN BINDING;

EID: 59649103839     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.08.016     Document Type: Review

References (71)

1. Krishna R.G., and Wold F. Post-translational modifications. In: Angeletti R.H. (Ed). Proteins: Analysis and Design (1998), Academic Press, San Diego, CA 121-207
2. Reinders J., and Sickmann A. Modificomics: post-translational modifications beyond protein phosphorylation and glycosylation. Biomol. Eng. 24 (2007) 169-177
3. Miller E.C., and Miller J.A. The presence and significance of bound aminoazo dyes in the livers of rats fed p-dimethylaminoazobenzene. Cancer Res. 7 (1947) 468-480
4. Miller J.A. Carcinogenesis by chemicals: an overview-G.H.A. Clowes Memorial lecture. Cancer Res. 30 (1970) 559-576
5. Scribner J.D., Miller J.A., and Miller A.C. 3-Methylmercapto-N-methyl-4-aminoazobenzene: an alkaline-degradation product of a labile protein-bound dye in the livers of rata fed N,N-dimetnyl-4-aminoazobenzene. Biochem. Biophys. Res. Commun. 20 (1965) 560-565
6. White A., and Jackson R.W. The effect of bromobenzene on the utilization of cystine and methionine by the growing rat. J. Biol. Chem. 111 (1935) 507-513
7. Baumann E., and Preusse C. Ueber bromophenylmercaptusaure. Chem. Berl. 12 (1879) 806-810
8. Jaffe M. Ueber die nach Einfuhrung von Bromobenzol und chlorobenzol im organismus entstehehden schwefelhaltigen sauren. Chem. Berl. 12 (1879) 1092-1098
9. Brodie B.B., Reid W.D., Cho A.K., Sipes G., Krishna G., and Gillette J.R. Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc. Natl. Acad. Sci. U.S.A. 68 (1971) 160-164
10. Jollow D.J., Mitchell J.R., Potter W.Z., Davis D.C., Gillette J.R., and Brodie B.B. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 187 (1973) 195-202
11. Mitchell J.R., Jollow D.J., Potter W.Z., Davis D.C., Gillette J.R., and Brodie B.B. Acetaminophen-induced hepatic nectosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187 (1973) 185-194
12. Evans D.C., Watt A.P., Nicoll-Griffith D.A., and Baillie T.A. Drug-protein covalent adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem. Res. Toxicol. 17 (2004) 3-16
13. Park K.B., Dalton-Brown E., Hirst C., and Williams D.P. Selection of new chemical entities with decreased potential for adverse drug reactions. Eur. J. Pharmacol. 549 (2006) 1-8
14. Park K.B., Ketteringham N.R., Maggs J.L., Pirmohamed M., and Williams D.P. The role of metabolic activation in drug-induced hepatotoxicity. Ann. Rev. Pharmacol. Toxicol. 45 (2005) 177-202
15. Boyland E. Biochem. Soc. Symp. 5 (1950) 40 et seq
16. Caldwell J. Drug metabolism and pharmacogenetics: the British contribution to fields of international significance. Br. J. Pharmacol. 147 (2006) s89-s99
17. Pohl L.R., and Krishna G. Deuterium isotope effect in bioactivation and hepatotoxicity of chloroform. Life Sci. 23 (1978) 1067-1072
18. Klaassen C.D., and Plaa G.L. Comparison of the biochemical alterations elicited in livers from rats treated with carbon tetrachloride, chloroform, 1,1,2-trichloroethane and 1,1,1-trichloroethane. Biochem. Pharmacol. 18 (1969) 2019-2027
19. Pohl L.R., and Gillette J.R. Determination of toxic pathways of metabolism by deuterium substitution. Drug Metab. Rev. 15 (1984) 1335-1351
20. Slaughter D.E., and Hanzlik R.P. Identification of epoxide- and quinone-derived bromobenzene adducts to protein sulfur nucleophiles. Chem. Res. Toxicol. 4 (1991) 349-359
21. Slaughter D.E., Zheng J., Harriman S., and Hanzlik R.P. Identification of covalent adducts to protein sulfur nucleophiles by alkaline permethylation. Anal. Biochem. 208 (1993) 288-295
22. Vogel E., and Günther H. Benzene oxide-oxepin valence tautomerism. Angew. Chem. Int. Ed. Engl. 6 (1967) 385-401
23. Jerina D.M., and Daly J.W. Arene oxides: a new aspect of drug metabolism. Science 185 (1974) 573-582
24. Dahlin D.C., and Nelson S.D. Synthesis, decomposition kinetics, and preliminary toxicological studies of pure N-acetyl-p-benzoquinone imine, a proposed toxic metabolite of acetaminophen. J. Med. Chem. 25 (1982) 885-886
25. Cooper A.J.L., and Pinot J.T. Cysteine S-conjugate beta-lyases. Amino Acids 30 (2006) 1-15
26. Anders M.W. Formation and toxicity of anesthetic degradation products. Ann. Rev. Pharmacol. Toxicol. 45 (2005) 14-176
27. Bailey M.J., and Dickinson R.G. Acyl glucuronide reactivity in perspective: biological consequences. Chem. Bio. Interact. 145 (2003) 117/137 145, 117-137
28. Cashman J.R., and Hanzlik R.P. Oxidation and other reactions of thiobenzamide derivatives of relevance to their hepatotoxicity. J. Org. Chem. 47 (1982) 4650-4745
29. Ikehata K., Duzhak T.G., Galeva N.A., Ji T., Koen Y.M., and Hanzlik R.P. Protein targets of reactive metabolites of thiobenzamide in rat liver in vivo. Chem. Res. Toxicol. 21 (2008) 1432-1442
30. LoPachin R.M., and DeCaprio A.P. Protein adduct formation as a molecular mechanism in neurotoxicity. Toxicol. Sci. 86 (2005) 214-225
31. Sayre L.M., Lin D., Yuan Q., Zhu X., and Tang Z. Protein adducts generated from products of lipid oxidation: focus on HNE and ONE. Drug Metab. Rev. 38 (2006) 651-675
32. Williams M.V., Wishnok J.S., and Tanntnbaum S.R. Covalent adducts arising from the decomposition products of lipid hydroperoxides in the presence of cytochrome c. Chem. Res. Toxicol. 20 (2007) 767-775
33. Calleman C.J., Ehrenberg B., Jansson B., Osterman-Galkar S., Segerbäck K., and Wachtmeister C.A. Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide. J. Environ. Pathol. Toxicol. 2 (1978) 427-442
34. Ogawa M., Oyama T., Isse T., Yamaguchi T., Murakami T., Endo Y., and Kawamoto T. Hemoglobin adducts as a marker of exposure to chemical substances, expecially prtr class i designated chemical substances. J. Occup. Health 48 (2006) 314-328
35. Wendel A., and Cikryt P. Binding of paracetamol metabolites to mouse liver glutathione S-transferases. Res. Commun. Chem. Pathol. Pharmacol. 33 (1981) 463-473
36. TPDB, The Reactive Metabolite Target Protein Database is a searchable, annotated compilation of protein targets for reactive metabolites of drugs and chemicals, It can be found at http://tpdb.medchem.ku.edu:8080/protein_database/.
37. Satoh H., Martin B.M., Schulick A.H., Christ D.D., Kenna J.G., and Pohl L.R. Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 322-326
38. Thomassen D., Martin B.M., Martin J.L., Pumford N.R., and Pohl L.R. Characterization of a halothane induced trifluoroacetylated 100 kDa neoantigen that is related to a glucose-regulated protein. FASEB J. 4 (1990) A599
39. Bartolone J.B., Birge R.B., Bulera S.J., Bruno M.K., Nishanian E.V., Cohen S.D., and Khairallah E.A. Purification, antibody production and partial amino acid sequence of the 58-kDa acetaminophen-binding liver proteins. Toxicol. Appl. Pharmacol. 113 (1992) 19-29
40. Pumford N.R., Martin B.M., and Hinson J.A. A metabolite of acetaminophen covalently binds to the 56-kDa selenium binding protein. Biochem. Biophys. Res. Commun. 182 (1992) 1348-1355
41. Qiu Y., Burlingame A.L., and Benet L.Z. Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. J. Biol. Chem. 273 (1998) 17940-17953
42. Asif A.R., Armstrong V.W., Voland A., Wieland E., Oellerich M., and Shipkova M. Proteins identified as targets of the acyl glucuronide metabolite of mycophenolic acid in kidney tissue from mycophenolate mofetil treated rats. Biochemie 89 (2007) 393-402
43. Druckova A., Mernaugh R.L., Ham A.L., and Marnett L.J. Identification of the protein targets of the reactive metabolite of Teucrin A in vivo in the rat. Chem. Res. Toxicol. 20 (2007) 1393-1408
44. Koen Y.M., Gogichaeva N.V., Alterman M.A., and Hanzlik R.P. A proteomic analysis of bromobenzene reactive metabolite targets in rat liver cytosol in vivo. Chem. Res. Toxicol. 20 (2007) 511-519
45. Koen Y.M., and Hanzlik R.P. Identification of seven proteins in the endoplasmic reticulum as targets for reactive metabolites of bromobenzene. Chem. Res. Toxicol. 15 (2002) 699-706
46. Koen Y.M., Williams T.D., and Hanzlik R.P. Identification of three protein targets for reactive metabolites of bromobenzene in rat liver cytosol. Chem. Res. Toxicol. 13 (2000) 1326-1335
47. Meier B.W., Gomez J.D., Zhou A., and Thompson J.A. Immunochemical and proteomic analysis of covalent adducts formed by quinone methide tumor promoters in mouse lung epithelial cell lines. Chem. Res. Toxicol. 18 (2005) 1575-1585
48. Bartolone J.B., Beierschmitt W.P., Birge R.B., Emeigh Hart S.G., Wyland S., Cohen S.D., and Khairallah E.A. Selective acetaminophen metabolite binding to hepatic and extrahepatic proteins: an in vivo and in vitro analysis. Toxicol. Appl. Pharmacol. 99 (1989) 240-249
49. Koen Y.M., Yue W., Galeva N.A., Williams T.D., and Hanzlik R.P. Site-Specific arylation of rat glutathione S-transferase A1 and A2 by bromobenzene metabolites in vivo. Chem. Res. Toxicol. 19 (2006) 1426-1434
50. Hanzlik R.P., Koen Y.M., Theertham B., Dong Y., and Fang J. The Reactive Metabolite Target Protein Database (TPDB)-a web-accessible resource. BMC Bioinform. 8 (2007) 95
51. McMillian M., Nie A.Y., Parker J.B., Leone A., Bryant S., Kemmerer M., Herlich J., Liu Y., Yieh L., Bittner A., Liu X., Wan J., and Johnson M.D. A gene expression signature for oxidant stress/reactive metabolites in rat liver. Biochem. Pharmacol. 68 (2004) 2249-2261
52. McMillian M., Nie A.Y., Parker J.B., Leone A., Kemmerer M., Bryant S., Herlich J., Yieh L., Bittner A., Liu W., Wan J., and Johnson M.D. Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver. Biochem. Pharmacol. 67 (2004) 2141-2165
53. Minami K., Saito T., Narahara M., Tomita H., Kato H., Sugiyama H., Katoh M., Nakajima M., and Yokoi T. Relationship between hepatic gene expression profiles and hepatotoxicity in five typical hepatotoxicant-administered rats. Toxicol. Sci. 87 (2005) 296-305
54. Steiner G., Suter L., Boess F., Gasser R., deVera M.C., Albertine S., and Ruepp S. Discriminating different classes of toxicants by transcript profiling. Environ. Health Perspect. 112 (2004) 1236-1248
55. Heijne W.H.M., Stierum R.H., Slijper M., van Bladeren P.J., and van Ommen B. Toxicogenomics of bromobenzene hepatotoxicity: a combined transcriptomics and proteomics approach. Biochem. Pharmacol. 65 (2003) 857-875
56. Ruepp S.U., Tonge R.P., Shaw J., Wallis N., and Pegnan F. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol. Sci. 65 (2002) 135-150
57. Boverhof D.R., and Zacharewski T.R. Toxicogenomics in risk assessment: applications and needs. Toxicol. Sci. 89 (2006) 352-360
58. Iida M., Anna C.H., Hartis J., Bruno M., Wetmore B., Dubin J.R., Siebert S., Bennerr L., Cunningham M.L., Paoles R.S., Tomer K.B., Houle C.D., Merrick A.B., Sills R.C., and Devereux T.R. Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. Carcinogenesis 24 (2003) 757-770
59. Barber D.S., Stevens S., and LoPachin R.M. Proteomic analysis of rat striatal synaptosomes during acrylamide intoxication at a low dose rate. Toxicol. Sci. 100 (2007) 156-167
60. Welch K.D., Wen B., Goodlet D.R., Yi E.C., Lee H., Reilly T.P., Nelson S.D., and Pohl L.R. Proteomic identification of potential susceptibility factors in drug-induced liver disease. Chem. Res. Toxicol. 18 (2005) 924-933
61. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., SchwikowskI B., and Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13 (2003) 2498-2504
62. Czaja M. Cell signaling in oxidtive stress-induced liver injury. Semin. Liver Dis. 27 (2007) 378-389
63. Genestra M. Oxyl radical, redox-sensitive signalling cascades and antioxidants. Cell. Signal. 19 (2007) 1807-1819
64. Cuevas B.D., Abell A.N., and Johnson G.L. Role of mitogen-activatged protein kinase kinase kinases in signal integration. Oncogene 26 (2007) 3159-3171
65. 2) terminal kinase in paracetamil-induced accute liver failure. Gut 56 (2007) 982-990
66. Johnson G.L., and Nakamura K. The c-Jun kinase/stress-activated pathway: regulation, function and role in human disease. Biochim. Biophys. Acta 1773 (2007) 1341-1348
67. Malemud C.J. Small molecular weight inhibitors of stress-activated and mitogen-activated protein kinases. Mini Rev. Med. Chem. 6 (2006) 689-698
68. Manning A.M., and Davis R.J. Targeting JN K for therapeutic benefit: from junk to gold?. Nat. Rev. Drug Discov. 2 (2003) 554-565
69. Cribb A.E., Peyrou M., and Muruganandan S. The endoplasmic reticulum in xenobiotic toxicity. Drug Metab. Rev. 37 (2005) 405-442
70. Marx J. A stressful situation. Science 313 (2006) 1564-1566
71. Schröder M., and Kohno K. Recent advances in understanding the unfolded protein response. Antioxid. Redox Signal. 9 (2007) 2241-2244